Sort   by:  
 Page size 
UnknownPhase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
Not available
S-EPMC3577951 | biostudies-literature
UnknownSafety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis.
Not available
S-EPMC6611608 | biostudies-literature
ProteomicsSystematic discovery of endogenous ribonucleoprotein complexes - RNA DIF-FRAC Human HEK293T Cells Replicate1
The associated files are mass spec data from size exclusion chromatographic separations of Human HEK293T with and without RNAse A treatment.
ORGANISM(S): Homo sapiens (Human) 
2019-10-18 | PXD015406 | Pride
Rbp Ribonucleoprotein complex Rnp Dif - frac Rna binding protein Proteomics Mass spectrometry Biochemical fractionation Protein complex es Interactome 
UnknownAddendum: independent optical excitation of distinct neural populations.
Not available
S-EPMC4920138 | biostudies-literature
TranscriptomicsAn epithelial-mesenchymal transition (EMT) gene signature predicts resistance to erlotinib and PI3K pathway inhibitors and identifies Axl as a novel EMT marker in non-small cell lung cancer.
Epithelial/mesenchymal transition (EMT) is associated with loss of cell adhesion molecules, such as E-cadherin, and increased invasion, migration, and proliferation in epithelial cancers. In non-small cell lung cancer (NSCLC), EMT is associated with greater resistance to EGFR inhibitors. However, it...
ORGANISM(S): Homo sapiens 
2012-10-25 | E-GEOD-33072 | biostudies-arrayexpress
GenomicsNational Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments

The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through identification of genomic changes associated with the follo...

phs000218.v5.p1 | EGA
UnknownThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490 | biostudies-literature
UnknownGlobal Retinoblastoma Presentation and Analysis by National Income Level.
Not available
S-EPMC7047856 | biostudies-literature
UnknownMapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018.
Not available
S-EPMC9760541 | biostudies-literature
UnknownThe ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Not available
S-EPMC9755784 | biostudies-literature
Sort   by:  
 Page size